The National Institutes of Health (NIH) intends to award a non-competitive contract to Oxford Nanopore Technologies Inc. for sequencing reagents, as only these reagents can produce the extremely long DNA reads required by the NIH Intramural Sequencing Center (NISC) to support over 50 laboratories. The contract will be conducted under simplified acquisition procedures, with a value not exceeding the simplified acquisition threshold of $350,000. Performance of services will be at the NIH facility in Bethesda, Maryland. Interested parties must submit responses by July 27, 2026, at 9:00 AM Eastern time. This notice is not a request for competitive proposals, but capability statements will be considered.